Calcitonin gene-related peptide (CGRP) plays a pivotal role in the pathophysiology of migraine and is an important therapeutic target. Monoclonal antibodies that inhibit CGRP binding to its receptor ...

Migraine is a chronic and debilitating neurological condition affecting women 3 to 4 more times than men. Despite an estimated 1.1 billion people being impacted by the condition, the physiological ...

Migraine is a common neurovascular disorder characterised by recurrent, unilateral headaches often accompanied by sensory disturbances. Its pathophysiology centres on aberrant activation of the ...

SAN DIEGO — Migraine is the third most common neurological disorder worldwide, and yet reliable treatments remain elusive. Research hinting at new avenues for treatments will be presented at ...

Fremanezumab, a humanized monoclonal antibody that selectively targets calcitonin gene–related peptide, is approved for the prevention of migraine in adults. Evidence from randomized, controlled ...

Magnetic resonance spectroscopy offers a noninvasive way to measure brain neurochemicals and metabolites during active ...

Not only do women get more migraines than men, but a new study shows they also experience them for a longer duration. Many scientists point to hormones as the cause of most migraines in women, but ...